Fuller & Thaler Asset Management, Inc. T2 Biosystems, Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$1.47 - $3.16 $464,743 - $999,040	-316,152 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$2.56 - $4.48 $168,064 - $294,112	-65,650 Reduced 17.19%	316,152 $831,000
Q4 2018 Feb 14, 2019	BUY	$2.98 - $6.86 $2,682 - $6,174	900 Added 0.24%	381,802 $1.15 Million
Q1 2018 May 14, 2018	SELL	$4.21 - $7.0 $120,406 - $200,200	-28,600 Reduced 6.98%	380,902 $2.47 Million
Q4 2017 Feb 12, 2018	SELL	$3.73 - $4.6 $465,504 - $574,080	-124,800 Reduced 23.36%	409,502 $1.69 Million
Q3 2017 Nov 08, 2017	SELL	$3.9 - $6.78 $9,750 - $16,950	-2,500 Reduced 0.47%	534,302 $2.24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	536,802	536,802 $1.72 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.88M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.